Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity
Microsatellite Instability
DOI:
10.3389/fcell.2021.729927
Publication Date:
2021-09-20T05:29:57Z
AUTHORS (5)
ABSTRACT
E1A binding protein p300 ( EP300 ) is mutated in diverse cancers. Nevertheless, a systematic investigation into the associations of mutations with genome instability and antitumor immunity pan-cancer remains lacking. Using datasets from The Cancer Genome Atlas, we analyzed correlations between immune response 11 cancer types. Compared to -wild-type cancers, -mutated cancers had significantly higher tumor mutation burden (TMB) 10 harbored much fraction microsatellite instable colon gastric was co-mutated genes involved DNA damage repair pathways multiple Furthermore, compared cytolytic activity scores ratios immune-stimulatory over immune-inhibitory signatures Also, showed programmed death-ligand 1 PD-L1 expression levels than increased TMB, activity, indicated favorable checkpoint inhibitors (ICIs) as evident three cohorts treated ICIs. Thus, could be predictive biomarker for immunotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....